by APFLI | Jan 28, 2005 | Contraception - Chemical Methods / Hormonal Contraception / Emergency / Morning After Pill
DEPO-PROVERA LABELED: LINKED TO BONE DENSITY LOSS The U.S. Food and Drug Administration (FDA) has issued a "black box warning" — the strongest possible FDA warning issued — to the labeling of the Depo-Provera drug, noting that extended use of...
